Fitting Response Curves for Radioimmunoassays or Immunoradiometric Assays by Altenburg, H. -P.
AUcnburg: Fitting RIA or IRMA response curves 873
Eur. J. Clin. Cheni. Clin. Biochem.
Vol. 32, 1994, pp. 873-880
© 1994 Walter de Gruyter & Co.
Berlin · New York
Fitting Response Curves for Radioimmunoassays
or Immunoradiometric Assays
By H.-R Altenburg
Med. Statistik, Biomathematik und Informationsverarbeitung, Fakultät für Klinische Medizin Mannheim der Uni-
versität Heidelberg, Heidelberg, Germany
(Received February 9, 1993/May 2/July 29, 1994)
Summary: The paper describes non-linear regression methods for the evaluation of radioimmunoassay or immuno-
radiometric assay data. The underlying model is an overdispersed Poisson process with four regression line parame-
ters and one parameter related to the overdispersion of the variance. A generalized least-squares algorithm is
described for the parameter estimation of non-contaminated data. In the presence of outliers in Y-direction, the
results are improved by a winsorized Version of the generalized least-squares method.
Introduction
Radioimmunoassays or immunoradiometric assays are
now Standard procedures for the estimation of hormones
and other materials in very small concentrations. The
use of natural proteins such äs thyropexin (thyroid hor-
mone binding globulin) (1) or antibodies (2) äs assay
reagents was described in 1960. Antigens or antibodies,
labelled with radiöisotopes, are incubated with the test
material, and the bound or free fraction of radiation is
determined. Methods using natural binding proteins (re-
ceptors) may give closer estimates of the biological ac-
tivity of a hormone, but antibodies, when specific and
of high titre, offer the advantage that they can be made
widely available and used over extended periods. Since
radioligand assays do not depend on responses measured
in living örganisms, they are not strictly bioassays. Nev-
ertheless they are so similar in structure that the
following model is considered from this viewpoint.
Many users of radioimmunoassays or immunoradiomet^
ric assays make no formal statistical analyses. In view
of the precision and the smoothness of the response
curves, they rely on reading from freehand curves con-
structed from the data. In particular, they neglect the
merits of simultaneous trials of Standard and test prepa-
rations, statistical tests of validity and1 the estimation of
error. Reliance on graphical methods might be satisfac-
tory, if the experimentation is well controlled and the
response curve appears very smooth. But for a more crit-
ical examination of the data, and the estimation of
Parameters according to recognized statistical principles,
statistical regression procedures must be used for the
analysis.
The plot of the observed counts against the logarithm of
the administered dose is usually a Symmetrie sigmoid
curve with an upper and lower asymptotic level corre-
sponding to the bound count at zero dose and the
non-specific count «, at "infinite" dose. Proposals for
calculating radioimmunoassay results include empirical
methods (e. g. spline function approach or point-to-point
Interpolation) and those in which it is assumed that the
Standard curve is a member of a particular family of
curves. Among the second group three families of
curves have been used: the logistic family, those based
on the law of mass action, and linear regression ap-
proaches. In the linear regression approach functions of
the observed counts such äs the "fraction bound", the
"fraction free", the "bound/initial bound ratio" or die
"bound/free ratio" and their reciprocals are normally
plotted against the dose or the logarithm of dose, and
any of these relationships will show an approximately
linear regression over some ränge of dose, but will al-
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most ccrtainly be disconcertingly non-linear if the ränge
is extended.
Also many radioimmunoassays are analysed using a lin-
ear regression analysis based on the logit-log trans^
formation of the data. For this transformation the count-
ing data must represent the percentage of specifically
bound material, i. e., the non-specific binding must be
subtracted from the counting data, which must then be
expressed äs a percentage of the control adjusted for
non-specific binding. Several problems arise in this type
of analysis. First, it is assumed that the control and non-
specific binding data are known exactly, when in fact
they are also subject to experimental error. Essentially,
this means that the endpoints of the curve are being
fixed. Second, the observed dose-response data some-
times appear outside these fixed asymptotic endpoints
(e. g. some observations are less than the non-specific
binding value). The logit-log analysis cannot handle data
like this and these data points can only be removed from
the analysis.
A mathematical model representing the statistical fea-
tures of experimental data should therefore concentrate
attention on the original observations rather than on de-
rived functions. This also allows the fitting of control
and non-specific binding levels. Additionally, data do
not have to be discarded if they fall outside an appropri-
ate ränge. Raab (3) and Finney (4) have pointed out that
the mass-action law approach can assume only a very
limited ränge of shapes, and cannot represent assays
where the Standard curve slope is less than a specified
value. However, a four- or five-parameter logistic model
will fit data at least äs well over a wide ränge of doses
in many but not all circumstances, particularly when
both the binding site concentration and the equilibriüm
constant are small.
Because radioligand assays are based upon records of
radiation counts in a fixed time at various doses, a quite
realistic assumption concerning the distribution of
counts is that they are realisations of some stochastic
Poisson process. Based on an overdispersed Poisson
model, one can express the expectation of the observed
counts by a four-parametric non-linear function. In con-
trast to the normal Poisson model, the marginal variance
depends on a further single parameter which addition-
ally has to be estimated. In the normal case, when the
data are not contaminated, a generalized least squares
technique can be used to estimate the parameters. Never-
theless, this type of model does not provide a good fit
for all experimental situations. The following sections
therefore describe the underlying mathematical model
and give an improved Version of the estimation algo-
rithm — a generalized least squares algorithm — äs pre- ·
sented by Altenburg & Rosenkranz (5). But, since radio-
immunoassay data often show outliers in Y-direction,
one has to use a robust estimation procedure to minimize
the influence of the outliers on the estimates. Different
robust estimation procedures have been compared by Al-
tenburg (6). Finally, therefore, a generalized least
squares algorithm is presented, which the author regards
äs the most robust version of the generalized least
squares technique. The aim of the paper is not only to
present estimation procedures for the single dose re-
sponse calibration, but also to give a procedure that can
simultaneously estimate several dose response curves in
different experimental situations, and which furthermore
can be easily implemented on a Standard statistical pack-
age.
1. The Underlying Model
Normally the expectation of the couüt (fixed time) in
a radiometric experiment is given by a four-parameter
sigmoid function:
= E[count | dose = x] =
SQ + pG(00 + 0j log x), (Eq. 1)
where x denotes the ligand concentration or the adminis-
tered dose, p = 5«, -^ 50 is the ränge of counts, 00 and
i, are curve parameters (real numbers): the concentra-
tion at which we observe the 50% effect (EC 50), and
the slope of the curve, respectively. G(z) is a function of
the administered dose z that changes smoothly from 0
to l äs z teüds to +00. Immunoradiometric assay curves
differ from radioiinmunoassay curves, in that G(z) be-
comes G*(z) = l - G(zj.
The monotone increasing funetion <7(
 0 + log x) cor-
responds in the four-parameter logistic curve, and in the
radioimmunoassay case to the logistic function
G(Ö0 + 0, log je) =
{ l - 1/(1 + exp(-(00 +
( l
log*))) tf* > 0,
if x = 0,
(Eq. 2)
which is called the LOGIT model. As in a quantal bioas-
say, we can allow other distribution functions, such äs
e. g. the PROBIT model
l - (00 + 0! log x) if x > 0
if x = 0,
(Eq. 3)
where ( /) is the distribution function of the Standard
normal distribution, or in more special scientific applica-
tions the WEIBULL modell
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Ο(Θ0 + 0i log Λ:) =
f l - exp(-exp(-(00 4- θ} log *))) if χ > 0
l l if χ = 0
(Eq.4)
Generally, no single fixed distribution will fit all situa-
tions. As Ratkowsky & Reedy (7) pointed out, the para-
metrization presented in Eq. l is the best one under
"close to linear" properties.
In the following we look only at a single treatment
group experiment, with dose levels x\, ...,xd and para-
meter vector Θ = ((50, p 00, ^i) to be estimated. If there
were no measurement errors in the process of recording
the counts, maximum likelihood theory could be applied
for parameter estimation. Unfortunately measurement
errors occur and the number of recorded counts is deter-
mined by the statistical nature of radioactive decay and
additional random erorrs. Thus the variance is expected
to be larger than the variance obtained from a Poisson
process alone.
In most applications one can suppose that the relative
measurement error is independent of the recorded
counts. Hence, assuming that the number of counts y,- at
concentration je/ conditional on the errors et form a se-
quence of independent random variables, then expecta-
tion and variance are given by
E[y/ 1 Θ, ej =
| Θ, eg] = 0,
= l,
Var[e/] = κ^ β/, uncorrelated
(Eq. 5)
(Eq. 6)
for every i = l, ..., d. The marginal moments of yt then
have the form
λ? = E\yt \ Θ] ^ S0 + pG(00 ·+ θι log x) (Eq. 7)
Λ? = Varty, j Θ] - λ? (l + x2 Af ), (Eq. 8)
where the variance contains an additional parame-
ter κ.
2. The Estimation Procedure
Because we are not able to model the distribution of
counts but only its first and second moment, maximum
likelihood estimates are not available. However, quasi-
likelihood methods (cf. Wedderbum (8) or McCullagh
(9)) imply that an estimate Θ of Θ is a root of the equa-
tions
- λ?Λ?Θ = 0, y = (Eq.9)
where — - denotes the partial derivation to they-th com-
ponent of Θ (e. g.
θ© ι ")· Q
uasi"likelihood estima-
tors have similar properties s maximum likelihood esti-
mators but in those cases where maximum likelihood
estimators exist they are less efficient.
To get the quasi-likelihood estimators, we can use the
non-linear estimation procedure of a statistical package
like the SAS procedure NUN, minimizing the function
d
S(&) =
/= i
with the weights
-l·
(Eq. 10)
f o r / = !,. . . ,</ (Eq. 11)
In terms of both point estimation, confidence interval
coverage and a computational point of view, Beal &
Sheiner (10) found that a generalized least squares tech-
nique is one of the test tractable estimating procedure
for a heteroscedastic problem of the present type. Start-
ing values for the parameters in step l and 2 of the
estimation algorithm are obtained s follows.
Step 0
Zero might be an adequate starting value for all the
curve parameters, 0o, &\ and the variance parameter κ.
The asymptotic level values SQ and &o are easily esti-
mated from the me n or median values of yh at the non-
specific (lowest) or asymptotic (highest) dose levels χ ι
or xj, respectively, from which we can compute the
starting value for p by
p = <L - <50. (Eq. 12)
In case of an immunoradiometric assay the roles of <50
and <5TO have to be interchanged.
Then the estimators Θ can be obtained by the following
algorithm Steps (κ^ and 0W denote the estimates in iter-
ation stepy):
Step l
Ordinary least squares estimator of Θ: Using the above
starting values calculate Θ(0) by minimizing the expres-
sion
t & ~ W- (Eq. 13)
/= l
Iterate the following two Steps fory = l, 2, ...:
Step 2
Given 6^" !) and j?0'""1} we can obtain the estimator
of κ by minimizing (with respect to κ):
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(Eq. 14)
where r/ = vj - Af0'0 are the residuals of stepy - l
and Af is according to Eq. 8.
Step 3
Weighted least squares estimator of Θ given /^
6^"!): Calculate Θω such that
and
(Eq. 15)
Step 2 and Step 3 have to be iterated at least two times
to eliminate the effect of the inefficient unweighted
least-squares estimate Θ(0). The Iteration ends if the
change of the estimate κ of the variance parameter is
less than a pregiven value ε. In our test data examples
we found that normally four or five Iteration cycles seem
to be sufficient for the estimation of the parameters of
one or two groups. In applications with more than two
groups the number of iterations has to be slightly
increased. The numerical calculations involved in the
three Steps of the algorithm can be done by the computa-
tional methods fMarquardt (in Step l and 3) or Gauss-
Newton (in Step 2).
3. A Non-Linear Robust Regression Method
Normally the technique of radioimmunoassay is proce-
durally complicated and it is not unusual that outliers
appear in the data. In the case of non-linear regression
the development of robust estimation procedures is not
free from troubles and consumes a Ipt of Computing
time. In Standard applications of the radioimmunoassay
technique, outliers or long-tailed distributions occur
only in the Y-direction, so it is assumed that estimation
procedures for M-estimates such s Huber type estima-
tion procedures deal adequately with outliers. As shown
in 1. c. (6) the best robust method for estimating radio-
immunoassay or immunoradiometric data according to
the above described overdispersed Poisson model is the
following procedure. The procedure uses metrical wi -
sorization of the data s described in Huber (11).
Winsorized Generalized Least Squares Algorithm
Step l
Start using the generalized least squares algorithm s
described in Section 2.
Step 2
Winsorize metrically the original observations y{ and re-
place them in the following way be pseudo-observa-
tions yl\
y = · , „ if iri ' ~+ sigii(r/)fo/ · rotherwise
where rf = yf — yg are the residuals, j/ are the actual
estimates of the Standard error of the residuals rh and j?,
are the last fitted values of yt. The constant k denotes a
tuning constant regulating the amount of robustness.
Step 3
On the basis of the Winsorized data set, estimate κ and
Θ by the procedure-Steps 2 and 3 of the generalized
least squares algorithm in Section 2.
Iterate Step 2 and 3 again until all observations or
pseudo-observations remain unchanged by Eq. 16. The
procedure converges and the result is a M^estimator. We
found that one needs about 22 Iteration cycles of Step 2
and 3 to get appropriate estimates. In our opinion good
choices for the tuning constant k are values with
l < k ^  2, e. g. k « 1.6. The contamination of the data
set should not be too high (at most 20%). The winsoriza-
tion procedure fails if outliers exist in both X-direction
and Y-direction. Theii a probabilistic technique like a
non-linear generalization of the least mediaii of squares
methods might be appropriate. Although the probabilis-
tic least median of squares procedure or related tech-
niques are formally easily extended to the non-linear re-
gression case, the computation of these estimators is far
from trivial.
4. Numerical Illustration and Discussion
An example is now presented to illustrate the above al-
gorithms. The data set given in table l is from Tiede &
Pagano (12) representing thyrotropin Standards. The
dose is measured in mIU/1. The outlier in this data set is
marked by an asterix. Instead of a zero dose in the origi-
nal data set we use a value of 0.01, because a value of
zero leads to an invalid expression in the term log(dose)
of the underlying model. In table 2 the estimation results
for this data set are given. Listed are the estimates for
Tab. l Data set of Tiede & Pagano (12).
Thyrotropin
dose
(mIU/1)
Radio-
activity
(counts/s)
0
7720
8113
2
6664
6804
5
4994
4948
. .
10
3410
3208
20
4478*
2396
50
1302
1377
100
1025
1096
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Tab. 2 Parameter estimates for Ihe data set of Tlecle & Pagano
(12) (tab. 1) for the probit model with Iogi0(</os<?), using different
estimation procedures ( LS = ordinary least squares, GLS = gen-
eralized least squares).
Procedure S E MSE
LS
LS no outlier
GLS
GLS no outlier
GLS winsorized
7967.02
7928.01
7728.06
7949.59
7938.36
-6947.08
-6851.40
-6705.25
-6894.66
-6890.50
.2731
.4986
.5082
.4533
.4457
.5207
.9084
.6908
.8521
.8204
__
—
0.04161
0.0007957
0.0007854
347.5
87.6
350.1
89.9
92.0
425709
20117
451207
20922
18910
Tab. 3 Estimated counts and effective concentrations with 95% confidcnce limits for the iterated
and winsorized generalized least squares algorithm.
Data Set: Tiede & Pagano (12) (tab. 1)
η
1
2
3
4
5
10
15
20
25
30
35
40
45
50
55
60
63
65
70
75
80
85
90
95
96
97
98
99
Iterated generalized least squares
Estimated
counts
7661.00
7593.95
7526.90
7459.85
7392.79
7057.53
6722.27
6487.01
6051.74
5716.48
5381.22
5045.96
4710.69
4375.43
4040.17
3704.91
3503.75
3369.64
3034.38
2699.12
2363.86
2028.59
1693.33
1258.07
1291.01
1223.96
1156.91
1089.86
Concen-
tration
ECri
0.328
0.476
0.602
0.719
0.830
1.362
1.901
2.479
3.112
3.818
4.614
5.523
6.571
7.798
9.253
11.011
12.253
13.179
15.927
19.539
24.533
31.987
44.662
73.250
84.606
101.007
127.833
185.296
Lower
95%
confidence
limit
0.0320
0.0560
0.0797
0.1040
0.1290
0.2699
0.4428
0.6547
0.9139
1.2304
1.6170
2.0901
2.6712
3.3882
4.2780
5.3900
6.1904
6.7901
8.5677
10.8450
13.7987
17.7226
23.2703
32.7175
35.7934
39.8153
45.6265
56.0552
Upper
95%
confidence
limit
3.361
4.042
4.546
4.968
5.432
6.869
8.163
9.384
10.598
11.848
13.167
14.592
16.167
17.947
20.015
22.493
24.254
25.578
29.608
35.202
43.617
57.731
85.719
163.997
199.985
256.243
358.153
612.517
Winsorized generalized least
Estimated
counts
7869.46
7800.55
7731.65
7662.74
7593.84
7249.31
6904.79
6560.26
6215.74
5771.22
5526.69
5182.17
4837.64
4493.12
4148.59
3804.07
3597.35
3459.54
3115.02
2770.49
2425.97
2081.44
1736.92
1392.39
1323.49
1254.58
1185.68
1116.77
Concen-
tration
ΕΟη
0.328
0.463
0.577
0.680
0.777
1.231
1.678
2.147
2.652
3.207
3.824
4.518
5.310
6.225
7.298
8.577
9.472
10.135
12.084
14.611
18.050
23.094
31.488
49.856
56.998
67.194
83.626
118.056
squares
Lower
95%
confidence
limit
0.2303
0.3349
0.4246
0.5075
0.5868
0.9653
1.3498
1.7611
2.2117
2.7127
3.2761
3.9166
4.6524
5.5073
6.5133
7.7147
8.5549
9.1756
10.9930
13.3236
16.4456
20.9228
28.1615
43.3916
49.1570
57.2763
70.1351
96.3992
Upper
95%
confidence
limit
0.468
0.641
0.783
0.911
1.030
1.569
2.086
2.617
3.181
3.791
4.463
5.212
6.061
7.037
8.176
9.535
10.488
11.194
13.284
16.022
19.811
25.490
35.208
57.284
66.089
78.829
99.712
144.578
the robust regression procedure described above under
the probit model set, compared with ordinary least
squares and generalized least squares \vith and without
the outlier. As a measure of robustness of the procedure
we use the sum of the absolute residuals r/
SAE=
and compare it with the classical mean squared error.
Table 3 lists the estimated counts and effective concen-
tration values ECr; for selected vahies of 77, l ^ η ^  99,
with the corresponding 95%-confidence limits for both
the generalized and the winsorized generalized least
squares algorithm. The confidence limits have been
computed from the final covariance matrix of the four
parameter estimates by the <5-method. The results in ta-
ble 3 are plotted in figures l and 2. We see that even a
single outlier can cause very large confidence intervals.
The ordinary least squares fit of this test data set shows
only slightly worse estimation results than the general-
ized least squares algorithm, and in many dose response
calibration situations the ordinary least squares approach
might therefore be sufficient for the corresponding prac-
tical applications. Possibly this example is a very ex-
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0.01 0.10 1.00 10.00
Thyrotropin [mlU/l]
Fig. l Estimated concentrations, generalized least squares algorithm
Probit model, dashed lines: 95% confidence limits of the thyrotropin concentrations.
100.00 1000.00
1000
0.01 0.10 1.00 10.00
Thyrotropin [mlU/l]
Fig. 2 Estimated concentrations, winsorized generalized least squares algorithm
Probit model, dashed lines: 95% confidence limits of the thyrotropin concentrations.
100.00 1000.00
treme case and "normal" outliers might leäd to smaller
differences in the confidence limits. The value of the
tuning constant used was k = 1.6. In the normal gener-
alized least squares case we needed 3 Iteration cycles
of Step 2 and 3, whereas the winsorized generalized
least squares required 22 Iteration cycles until con-
vergence.
One can imagine many similar experimental situations
but one cannot test the estimation procedures in all of
them. In the Standard applications tested, we found that
the winsorization works well if we have outliers in the
Y-direction and the resulting parameter estimates are M-
estimates. The method might fail if we have outliers in
both the X- and Y-directions, and in such a case the
procedure may produce little improvement. This might
happen if the dose values are the result of a thmning
process in the experiment, where each thinning Step
leads to errors. The corivergence of the winsorization
could be very slow for an extreme data constellation. ·
The number of Iteration cycles changes, depending on
the number of groüps or the underlying experimental
Situation, such äs the number of comparisons. A large
number of groüps increases the number of Iteration
eycles, whereas a parallel-line assay (äs described in
the following) needs fewer iteratioiis than. a generäl
assay. The present example shows that a heteroscedas-
tic non-linear regression procedure is not robust
against outliers.
The estimation procedures described above are valid'not
only for the simple estimation of the parameters of a
single dose response curve of the form (Eq. 1), but also
in generäl situations like the estimation of the parame-
ters for comparing several treatment groüps or for esti-
mating relative potencies. To iltustrate this we assutiae
in the following that two treatment groüps are under
study. A first Step in comparing two different treatments
should be to exaniine whether two parallel dose re-
sponse lines with common asymptotic levels
 0 and 5«
must be considered. To test Uns we jointly estimate the
Eur. J. Clin. Cherh. Clin. Biochem. / Vol. 32,1-994 / No. 11
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six parameters 5o, p, 00> ,, Θ2, Θ3 in the following two
equations:
for χ from treatment group l:
λ = δ<> + pG(00 + 0! log je), (Eq. 18)
for χ from treatment group 2:
λ = Q + pG(00 + 0i log* + 0 2 + 0 3 log*),
(Eq. 19)
If the dose response curves are not parallel, the estimator
of 03 will be significantly different from zero, e. g. for
an error level of a = 0.05 if 03/ Var [03] > 1.96. The
variance Var [03] is obtained from the parameter esti-
mates covariance matrix.
When the hypothesis of parallelism cannot be rejected,
the data are sufficiently described by a common slope
for both curves. Thus it is enough to estimate simulta-
neously the five parameters δ0, ρ, Θ0, θι, Θ2 in the equa-
tions
λ = A + pG(00 + 0! log x),
for treatment group l
0i log*),
for treatment group 2.
(Eq. 20)
(Eq.21)
Now the two treatments can be compared in terms of
their relative potency π. The relative potency specifies
how many more dose units in treatment one must be
administered to obtain the same eifect s treatment 2.
The logarithm of π is given by
log;r = 02 - 0Q
01
(Eq.22)
If the hypothesis of parallelism is rejected, six curve
parameters 50, p, 0ο, θ\9 Θ2, Θ3 have to be estimated
simultaneously and no relative potency can be calcu-
lated. The equations to be estimated in a two treatment
group experiment are
~ δο + pG(00 + 0ilQg;c),
for treatment group l (Eq. 23)
λ = 50 + pG(02 + 03 log x),
for treatment group 2. (Eq. 24)
The advantage of this approach is its smaller variances,
thereby reducing the confidence limits for the effective
concentrations. The generalization to more than two
treatment groups is apparent.
Such an approach allows the parameter estimation in
many different experimental situations, and the win-
sorized alternative of the generalized least squares algo-
rithm is useful if we have outliers and do not want to
repeat the measurement. Nevertheless the proposed al-
gorithms fail if the specified model is not a correct de-
scription of the real experimental Situation. In that case
the final covariance matrix could be underestimated, es-
pecially in the winsorized approach, and the resulting
confidence limits for the effective concentrations would
be too narrow. Certainly the described model with the
proposed estimation procedures does not fit all conceiv-
able experimental situations. We can also transfer modi-
fied versions of the described procedures to non-ra-
diometric assay methods such s ELISA experiments.
But in this case an overdispersed Poisson model with
the variance term given in Eq. 11 does not come into
consideration.
The computations were done on -a personal Computer
with the Statistical Analysis System. Both procedures
for the parameter estimation s well s the computation
of the effective concentration values and the graphics
Output are realized within this System s macro pro-
cedures. Especially in the case of many group compari-
sons the use of a fast personal Computer is recom-
mended, because the procedure otherwise consumes a
lot of calculating time. For example, in the different iter-
ation Steps one has to perform the Gauss-Newton (esti-
mation of the variance parameter κ) or Marquardt algo-
rithm (estimation of the curve parameter), each needing
between 12 (at the beginning) and one Iteration (in the
final Step). The use of a fast programming language like
TURBO PASCAL therefore has advantages but requires
a lot of programming expenditure for the realization of
many different experimental situations.
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